Neil Desai, Executive Chairman at Aadi Bioscience, Inc. (AADI), sold 84,000 shares at $4.37 ($358K) on 2023-10-02, disclosed to the SEC on 2023-10-03.
Open-market sale of $358k AADI by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.37 | 25,569 | $112K | 31.2% |
| 2 | $4.37 | 25,569 | $112K | 31.2% |
| 3 | $4.10 | 16,431 | $67K | 18.8% |
| 4 | $4.10 | 16,431 | $67K | 18.8% |
| Total | $4.26 avg | 84,000 | $358K | 100% |
| Filing → |
| AADI | SELL | 2024-07-02 | $57K | — | Filing → |
| AADI | SELL | 2024-06-05 | $72K | — | Filing → |
| AADI | SELL | 2024-05-01 | $77K | — | Filing → |